Adam Powell

Adam Powell supports the Food and Drug Administration’s Office of Acquisition and Grant Services in executing mission-critical procurement activities aligned with regulatory science and public health protection. He manages the acquisition of high-precision analytical instrumentation, laboratory infrastructure, and specialized scientific services essential to FDA’s oversight of pharmaceuticals, biologics, and medical devices. His portfolio centers on technical procurement requiring deep domain expertise in laboratory operations, toxicology, and diagnostic testing, ensuring the agency maintains cutting-edge capabilities for product evaluation and safety monitoring. Powell’s work directly enables the FDA’s scientific integrity and regulatory decision-making through timely, compliant, and technically sound contracting. His primary contractor relationships include TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC, TOXICOLOGIC PATHOLOGY ASSOCIATES INC, and PROGENICS PHARMACEUTICALS INC, reflecting a focus on niche scientific and clinical support providers. These partnerships are characterized by long-term, performance-based engagements for specialized testing, analytical validation, and research services critical to preclinical and regulatory submissions. Powell prioritizes vendors with proven expertise in GMP, GLP, and FDA-regulated environments, fostering collaborations that ensure technical rigor and compliance with federal standards. While the majority of his acquisitions—73.7%—are conducted without set-asides, he consistently supports small business participation through Total Small Business Set-Asides under FAR 19.5, accounting for 26.3% of his awards. This reflects a deliberate strategy to leverage small business innovation while maintaining the technical capacity required for complex regulatory science. His contracting patterns demonstrate a balanced approach: prioritizing mission-critical performance while actively expanding opportunities for qualified small businesses in the life sciences sector. His procurement focus is overwhelmingly concentrated in NAICS 334516 (Analytical Laboratory Instrument Manufacturing), underscoring his specialization in acquiring mass spectrometers, chromatography systems, and other high-end analytical equipment. He also procures testing laboratory services (NAICS 541380) and in-vitro diagnostic substances (NAICS 325413), demonstrating deep technical fluency in laboratory automation, assay validation, and clinical diagnostics infrastructure.